JangoBio
Fitchburg
About JangoBio
JangoBio is a biotechnology company that develops regenerative therapies to reverse hormone imbalances associated with ageing and thereby mitigate the risk of developing age-related diseases. Their pharmaceutical treatments include hormone supplementation and underlying loss of functions. They specialize in ageing and age-related diseases by restoring hormone balance using regenerative stem cell therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Seed (Jan 2018)
- Website: jango.bio
- Phone: +1 833 465 2646
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/jangobio-152367 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.